Orbion Pharms

Orbion Pharmaceuticals is a specialty pharmaceutical company and Contract Development and Manufacturing Organization (CDMO) based in Hyderabad, India. The company specializes in the development and manufacturing of high-quality finished dosage forms, including oral solids, liquids, and topical preparations. Orbion operates state-of-the-art manufacturing facilities that are designed to comply with international regulatory standards such as the US FDA and EU GMP. In early 2024, Laurus Labs acquired a 76% stake in the company to enhance its formulation capabilities and expand its global market reach. Orbion provides comprehensive services ranging from formulation R&D to commercial-scale production for the global generic pharmaceutical industry.